Based on The Human Protein Atlas (46), higher expression of SH3BP4 is associated with better survival in stage I-III renal cancer (N=742; log-rank p=8×10-6), and the same trend was observed in CM-specific patients, albeit not statistically significant, possibly due to the limited sample size (N=98; log-rank p=0.14; Figure 2D). This evidence concerns the gene SH3BP4 and renal carcinoma.